A promising ‘single’ and ‘dual’ drug-nanocomposite enriched contact lens for the management of glaucoma in response to the tear fluid enzyme
B. N. Kumara, K. Velmurugan, Manisha Ghate, Rashmi Shambhu, Jayabalan Nirmal, K. Sudhakara Prasad
Abstract
safety evaluations of CLs on New Zealand white rabbit eyes suggest no sign of irritation to the ocular tissues within 72 h of observation. Hence, the study suggests that the 'single' and 'dual' drug-loaded CLs could open a new avenue to manage glaucoma by maintaining mean diurnal IOP.
Topics & Concepts
GlaucomaIntraocular pressureOphthalmologyContact lensGanglionDrugMedicineRetinalOptometryPharmacologyAnatomyOcular Surface and Contact Lens